Literature DB >> 11781492

A comparison of the supramolecular structures of 1-(6-amino-1,3-benzodioxol-5-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one and 1-(6-amino-1,3-benzodioxol-5-yl)-3-[4-(N,N-dimethylamino)phenyl]prop-2-en-1-one.

John N Low1, Justo Cobo, Manuel Nogueras, Adolfo Sánchez, Andrea Albornoz, Rodrigo Abonia.   

Abstract

1-(6-amino-1,3-benzodioxol-5-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one, C19H19NO6, (I), contains an intramolecular N-H...O hydrogen bond and a weak C-H...O hydrogen bond, which forms a C10 chain motif running parallel to the c axis. The 6-amino-1,3-benzodioxol-5-yl moieties are involved in pi-pi stacking. 1-(6-amino-1,3-benzodioxol-5-yl)-3-[4-(N,N-dimethylamino)phenyl]prop-2-en-1-one, C18H18N2O3, (II), crystallizes with two molecules in the asymmetric unit. The main feature of the supramolecular structure of (II) is the formation of a centrosymmetric hydrogen-bonded tetramer with an R8(4)(16) motif.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11781492     DOI: 10.1107/s0108270101018297

Source DB:  PubMed          Journal:  Acta Crystallogr C        ISSN: 0108-2701            Impact factor:   1.172


  4 in total

1.  1-(4-Amino-phen-yl)-3-[2-(trifluoro-meth-yl)phen-yl]prop-2-en-1-one.

Authors:  Jing Peng; Huifen Xu; Zhe Li; Yuyan Zhang; Jianzhang Wu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-04-24

2.  (E)-1-(3-Bromo-phen-yl)-3-(4-ethoxy-phen-yl)prop-2-en-1-one.

Authors:  Hoong-Kun Fun; Suchada Chantrapromma; P S Patil; S M Dharmaprakash
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-06-28

3.  1-Phenyl-3-(2,4,6-trimethoxy-phen-yl)prop-2-en-1-one.

Authors:  Jianzhang Wu; Li Zhang; Jing Wang; Shulin Yang; Xiaokun Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-23

4.  (E)-1-(1,3-Benzodioxol-5-yl)-3-(3-bromo-phen-yl)prop-2-en-1-one.

Authors:  Hongqi Li; T V Sreevidya; B Narayana; B K Sarojini; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.